Literature DB >> 3456344

Complete characterization and sequence of an HLA class II DR beta chain cDNA from the DR5 haplotype.

V L Tieber, L F Abruzzini, D K Didier, B D Schwartz, P Rotwein.   

Abstract

The human major histocompatibility complex includes the DP, DQ, and DR subregions, each of which contains at least one alpha chain gene and two beta chain genes. The products of the alpha chain gene and a beta chain gene from a given subregion combine to form a heterodimer which is found predominantly on the surface of immunocompetent cells, and is essential for effective cell-cell interactions and the generation of an immune response. The beta chain of the DR molecule is highly polymorphic, and it is this polymorphism which is thought to be ultimately responsible for the specific immune responsiveness and disease predisposition conferred by different DR molecules. While the sequences of DR beta chains of the homozygous DR1 cells, homozygous DR2, homozygous DR4, DR3/w6 cells and DR4/w6 genotypes have been partially or completely characterized, no sequence is yet available for the DR beta chain from a homozygous DR5 cell. A cDNA library was therefore constructed from the Swei cell line homozygous for the DR5 haplotype. A beta chain clone was isolated, characterized, and sequenced. Comparison with previously published DR beta chain restriction endonuclease maps and nucleotide sequences demonstrated that this clone was a DR beta chain clone. Comparison of the deduced amino acid sequence with other DR beta chain amino acid sequences shows three regions of variability in the first external domain, corresponding to amino acid residues 9-13, 26-38, and 67-74. The sequence of each of these variable regions in the beta chain from DR5 cells was identical or nearly identical to the sequences of variable regions found in the beta chains of other DR haplotypes, supporting the notion of gene conversion as an evolutionary mechanism generating polymorphism. The second external domain, and transmembrane and intracytoplasmic regions show a high degree of sequence conservation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3456344

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Nomenclature for factors of the HLA system, 1991. The WHO Nomenclature Committee for factors of the HLA system.

Authors: 
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Nucleotide sequence of a dog DRB cDNA clone.

Authors:  U M Sarmiento; R Storb
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

Review 3.  The structural basis of alloreactivity.

Authors:  R Lechler; G Lombardi
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

4.  Two distinct subtypes of the HLA-DRw12 haplotypes in the Japanese population detected by nucleotide sequence analysis and oligonucleotide genotyping.

Authors:  A Abe; I Ito; M Ohkubo; T Kaneko; K Ito; H Kato; N Kashiwagi; F Obata
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

5.  Nomenclature for factors of the HLA system, 1989. The WHO Nomenclature Committee.

Authors: 
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

6.  Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box.

Authors:  D K Didier; J Schiffenbauer; S L Woulfe; M Zacheis; B D Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

7.  Two DR beta allelic series defined by exon II-specific synthetic oligonucleotide genomic hybridization: a method of HLA typing?

Authors:  I Le Gall; P Millasseau; J Dausset; D Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

8.  Human allospecific TLCs generated against HLA antigens associated with DR1 through DRw8. II. Population analyses and blocking studies with monoclonal antibodies.

Authors:  S Rosen-Bronson; A H Johnson; R J Hartzman; D D Eckels
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

9.  HLA gene amplification and hybridization analysis of polymorphism. HLA matching for bone marrow transplantation of a patient with HLA-deficient severe combined immunodeficiency syndrome.

Authors:  L A Baxter-Lowe; J B Hunter; J T Casper; J Gorski
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

10.  Isolation and characterization of major histocompatibility complex class IIB genes from the nurse shark.

Authors:  S Bartl; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.